Cite
HARVARD Citation
Jadhavar, P. et al. (2016). Targeting prostate cancer with compounds possessing dual activity as androgen receptor antagonists and HDAC6 inhibitors. Bioorganic & medicinal chemistry letters. 26 (21), pp. 5222-5228. [Online].